Vietnam's tobacco tax reform receives WHO award, projected to boost annual revenue by $900 million

Sep.28.2025
Vietnam's tobacco tax reform receives WHO award, projected to boost annual revenue by $900 million
The WHO Western Pacific Regional Director recently presented the WHO Global Award to Vietnamese Minister of Health Đào Hồng Lan. The tax reforms in the newly revised 2025 Special Consumption Tax Law will enable 2.1 million people in Vietnam to quit or not start smoking by 2031, and will also generate an additional VND24 trillion (US$910 million) in annual state revenue.

Key Points:

 

·The WHO Western Pacific Regional Director recently presented the WHO Global Award to Vietnamese Minister of Health, Đào Hồng Lan.

·Tax reforms under the revised 2025 Special Consumption Tax Law will enable 2.1 million people in Vietnam to quit or not start smoking by 2031.

·This policy will also generate an additional VND24 trillion (approximately US$910 million) in national revenue annually.

 


 

2Firsts, September 28, 2025 - According to the official website of the Vietnamese Ministry of Health (MOH) on September 26, the World Health Organization (WHO) announced in Vietnam that new modeling results show that the country's recent tobacco tax reforms have brought health and economic benefits. The WHO Western Pacific Regional Director, Dr. Saia Ma'u Piukala, recently presented the WHO Global Award to Vietnamese Minister of Health, Đào Hồng Lan.

 

WHO modeling predicts that the tax reforms in the revised 2025 Special Excise Tax Law will enable 2.1 million people in Vietnam to quit or not start smoking by 2031, and will prevent 700,000 premature deaths over the next few decades. The policy will also generate an additional VND24 trillion (US$910 million) in state revenue annually while limiting access to cheaper tobacco brands for young people.

 

The release of these figures comes as the WHO, at the Fourth High-Level Meeting of the United Nations General Assembly on Non-communicable Diseases, called for strong measures to reduce leading global causes of death such as cancer, stroke, and heart disease.

 

At a side event at the UN conference, WHO Director-General Dr. Tedros Adhanom Ghebreyesus emphasized that "health taxes are a win-win solution: they not only prevent disease by reducing the consumption of harmful products, but also generate revenue to support countries' reinvestment in health and development."

 

Over the past decade, approximately one-quarter of WHO member states have increased tobacco taxes, raising the effective price of tobacco by at least 50%. Dr. Tedros thanked those who are committed to implementing tax policies to protect public health, strengthen domestic finances, and advance the Sustainable Development Goals. In June, Dr. Tedros also congratulated Vietnam on its tobacco tax reforms.

 

Dr. Angela Pratt, WHO Representative to Vietnam, said Vietnam's decision to reform tobacco taxes is a crucial step in reducing the country's still-high smoking rates, particularly among men, and protecting future generations from the harms of tobacco. She also commended Vietnam for the tobacco tax reform bill passed in June 2025, which introduced a fixed excise tax and set annual tax increases from 2027 to 2031. These reforms aim not only to increase tobacco taxes but also to ensure long-term reductions in tobacco consumption.

 

Jeju Health Center to Apply Conventional Tobacco Rules to Liquid E-Cigarettes From April 24
Jeju Health Center to Apply Conventional Tobacco Rules to Liquid E-Cigarettes From April 24
Jeju Health Center said it will apply the same regulations used for conventional tobacco products to all tobacco products, including liquid e-cigarettes, from April 24, while also strengthening public guidance and smoke-free zone management.
Apr.21 by 2FIRSTS.ai
Bloomberg: Zyn’s Dry-Mouth Problem Threatens Its Hold on Nicotine Pouch Market
Bloomberg: Zyn’s Dry-Mouth Problem Threatens Its Hold on Nicotine Pouch Market
According to Bloomberg, Philip Morris International’s Zyn is facing growing competition in the U.S. nicotine pouch market as consumers shift toward moister alternatives such as British American Tobacco’s Velo Plus.
BATPMI
May.22
FDA Defines Enforcement Focus for Unauthorized E-Cigarettes and Nicotine Pouches
FDA Defines Enforcement Focus for Unauthorized E-Cigarettes and Nicotine Pouches
The U.S. Food and Drug Administration issued guidance on May 8, 2026, titled “Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization.” The document describes FDA enforcement policies for certain electronic nicotine delivery system products and nicotine pouch products marketed without premarket authorization.
May.09 by 2FIRSTS.ai
Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million
Ispire Technology reported financial results on May 7, 2026, for the third quarter of fiscal 2026, covering the three months ended March 31, 2026. Revenue was $18.7 million, compared with $26.2 million in the third quarter of fiscal 2025 and $20.3 million in the prior quarter. Gross profit was $2.0 million, with gross margin of 10.7%. Net loss was $9.5 million, or $0.17 per share. The company said it held $18.0 million in cash as of March 31, 2026, up $468,000 sequentially.
May.08 by 2FIRSTS.ai
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
Altria’s USSTC to Close Nashville Plant and Shift Operations to Kentucky by 2028
Altria’s USSTC to Close Nashville Plant and Shift Operations to Kentucky by 2028
U.S. Smokeless Tobacco Company (USSTC), a subsidiary of Altria Group, announced plans to close its Nashville manufacturing facility by 2028 and consolidate production operations at a new facility in Hopkinsville, Kentucky.
Market
Jun.02